Dr. Baliga's 'Podkasts for Curious Docs'

Dr. Baliga's 'Podkasts for Curious Docs'

New Lancet Seminar on heart failure with reduced ejection fraction.  💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. It’s a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice. Tune in to explore the science, the strategy, and the future of treating HFrEF. 🫀🔬✨  🫀🔬✨

Dr. Baliga's 'Podkasts for Curious Docs'

🔍💓 Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts   Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it.   From CT angiography that unmasks non-obstructive plaque 🖥️➡️🫀 to stress PET/CMR that maps true ischemia under load 💨📊, multimodality imaging is redefining diagnosis, risk, and long-term outcomes.   The evidence is clear: better imaging leads to better prevention—and in many cases, fewer invasive...

Dr. Baliga's 'Podkasts for Curious Docs'

Exploring David Hume 🧠✨ Just revisited David Hume’s extraordinary contributions to modern thought — a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, economics, and evidence-based decision-making. 🌍📚 Hume challenges us to look closely, question boldly, and reason with humility — a timeless guide for scholars, clinicians, and leaders navigating uncertainty. 🔍💡 #Philosophy #Hume...

Dr. Baliga's 'Podkasts for Curious Docs'

The U.S. heart failure landscape is transforming—and fast. 🫀📊   A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. 📉⚖️   These trends demand a new generation of HF trials—more inclusive, prevention-focused, metabolism-centered, and designed to capture outcomes beyond cardiovascular death. 🚀🧬   A powerful reminder: heart failure is not inevitable—but the way we...

Dr. Baliga's 'Podkasts for Curious Docs'

🧬⏳ New Insights into Organ-Specific Aging! 🧠❤️🩺   Just explored a remarkable Nature Aging study showing how organ-specific proteomic clocks can forecast disease, cognitive decline, and even longevity with impressive precision. These clocks—built from >2,900 plasma proteins—reveal that the brain, kidney, and arteries age on their own timelines, each carrying unique clues about future health.   What struck me most is how brain aging outperforms traditional risk markers, predicting dementia even after accounting for age, APOE genotype, and cognitive scores. A...

Dr. Baliga's 'Podkasts for Curious Docs'

Respiratory vaccines are not just infection-fighters—they’re cardiovascular protectors. 💉🫀 The 2025 JACC Consensus reminds us that influenza, pneumococcal, COVID-19, RSV, and zoster vaccines reduce MI, HF decompensation, hospitalizations, and death in our most vulnerable patients.   As clinicians, we hold the power to translate evidence into prevention: strong recommendations, simple pathways, and clear conversations can save lives long before interventions do. 🌟   Vaccinate to protect the heart. Shield to preserve life. Prevent to empower patients. ❤️‍🩹  ...

Dr. Baliga's 'Podkasts for Curious Docs'

The latest JAMA article on keratinocyte carcinomas 🌞—a timely reminder that BCC and cSCC remain the world’s most common cancers, with more than 5.4 million cases annually in the US alone . The review highlights essential updates in epidemiology, high-risk features, prevention, and evidence-based management, especially the role of sun protection, actinic keratosis treatment, and risk-stratified surgical care 🔬⚕️. A great resource for clinicians committed to early detection, thoughtful treatment, and lifelong surveillance of at-risk patients 👀🛡️. If you work in dermatology,...

Dr. Baliga's 'Podkasts for Curious Docs'

🚨 Food Anaphylaxis: New Mechanisms Unveiled 🍽️🧬   A superb NEJM review highlights how cysteinyl leukotrienes act as gatekeepers in the gut—opening antigen passages, expanding mast cells, and amplifying the risk of oral anaphylaxis. The work elegantly bridges basic lipid biology with real-world food allergy challenges, and points toward new preventive strategies beyond current IgE-based therapies.   🔍 A must-read for clinicians, scientists, and anyone navigating severe food allergies.

Dr. Baliga's 'Podkasts for Curious Docs'

🌿 What does the evidence really say about medical cannabis? A new JAMA review highlights a clear message: cannabis helps few conditions—and harms may outweigh benefits for many. 📉 Small benefit for nausea ⚡ Moderate benefit for select pediatric seizures 💊 Limited evidence for pain, insomnia, or psychiatric use ❤️ Risks rise with high-potency products, especially for heart and mental health.   🧭 Clinicians: guide with evidence, screen carefully, use lowest-risk options.

Dr. Baliga's 'Podkasts for Curious Docs'

Thrilled to see a major step forward in dengue prevention! 🦟💊 A new NEJM study reports that daily mosnodenvir, a first-in-class antiviral targeting the NS3–NS4B interaction, significantly reduced DENV-3 viral load and prevented infection in a controlled human challenge model. 📉🧬 It’s early, but the results offer real hope for a long-awaited oral dengue prophylaxis—with encouraging safety, strong PK, and dose-dependent efficacy. 🚀🌍 Exciting moment for global infectious-disease innovation and antiviral development. 🙌✨